Cannabix Technologies Inc. (BLO.CN)

0.4650 -0.1250 (-21.19%) At close: 03:53PM EDT

Cannabix Technologies Inc.

3292 Production Way
Suite 501
Burnaby, BC V5A 4R4
Canada
604 551 7831
https://cannabixtechnologies.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ravinder S. Mlait B.A., BA, M.B.A., MBA	CEO & Director	163.5k	N/A	1976
Mr. Bryan E. Loree B.A., C.M.A., CPA, CMA	CFO, Corporate Secretary & Director	145.5k	N/A	1976
Dr. Rajpaul Attariwala M.D., Ph.D.	Chief Scientific Officer & Independent Director	150k	N/A	1968
Dr. Moe Paknahad Ph.D.	Vice President of Technology Development	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use; MS breath sampler; and contactless alcohol breathalyzer, as well as breath collection units. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.

Corporate Governance

Cannabix Technologies Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.